bpc-157 structure Chemical structures of BPC 157 metabolites as presented by He et al BPC-157 Clinical Profile | Research

The Canadian regulatory environment creates specific considerations for peptide sourcing

This means it can dissolve in water and travel through the bloodstream

Clinical use typically falls in the 100300 mcg subcutaneous range, administered before sleep

Other clinical insights Russian doctors flagged: - Selank + Semax is common for cognitive use, but can worsen anxiety in already-anxious individuals (Semax is stimulating) - Injectable BPC-157 has much stronger neurotransmitter effects than the oral capsule - Capsule BPC-157 is preferred for gut-only applications (IBS, inflammatory bowel issues) - In cautious protocols, bioregulator peptides should precede BPC-157 There's a wide gap between how peptides are marketed in the West and how they're used in Russian clinical practice